Lawmakers Blast FDA’s Decision To Approve Opioid Zohydro ER

Washington Drug Letter
A A
Several House members are calling on the FDA to strip Zohydro ER, Zogenix’s opioid painkiller, of its approval until the company can instill an abuse-deterrent formulation of the product.

To View This Article:

Login

Buy This Article Now

Add this article to your cart for $25.00